Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market buy Director bought 250,000 shares at $9.15 ($2,287,500)
  6. 4 Open-market buy Director bought 32,000 shares at $9.15 ($292,800)
  7. 4 Open-market buy Director bought 5,000,000 shares at $9.15 ($45,750,000)
  8. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 6,530 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Medical Officer gave up 1,577 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Operating Officer gave up 1,577 shares (to pay taxes)
  11. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Operating Officer gave up 1,395 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
  14. 4 Open-market buy Director bought 10,000 shares at $5.56 ($55,600)
  15. 4 Open-market buy Director bought 5,000,000 shares at $5.30 ($26,500,000)
  16. 4 Shares withheld for taxes Interim CEO & General Counsel gave up 8,851 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Medical Officer gave up 1,395 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Operating Officer gave up 1,395 shares (to pay taxes)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 18 · 352 filings